Home Cart 0 Sign in  

[ CAS No. 84228-44-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 84228-44-4
Chemical Structure| 84228-44-4
Structure of 84228-44-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 84228-44-4 ]

Related Doc. of [ 84228-44-4 ]

Alternatived Products of [ 84228-44-4 ]

Product Details of [ 84228-44-4 ]

CAS No. :84228-44-4 MDL No. :MFCD01320686
Formula : C8H8ClNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :WKVJBYKFGNVWLM-UHFFFAOYSA-N
M.W : 185.61 Pubchem ID :1515284
Synonyms :

Calculated chemistry of [ 84228-44-4 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 47.14
TPSA : 52.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.48 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.89
Log Po/w (XLOGP3) : 2.75
Log Po/w (WLOGP) : 1.72
Log Po/w (MLOGP) : 1.91
Log Po/w (SILICOS-IT) : 1.61
Consensus Log Po/w : 1.98

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.96
Solubility : 0.203 mg/ml ; 0.00109 mol/l
Class : Soluble
Log S (Ali) : -3.5
Solubility : 0.0582 mg/ml ; 0.000314 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.73
Solubility : 0.344 mg/ml ; 0.00185 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.42

Safety of [ 84228-44-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H302-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 84228-44-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 84228-44-4 ]
  • Downstream synthetic route of [ 84228-44-4 ]

[ 84228-44-4 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 84228-44-4 ]
  • [ 2486-71-7 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: With sodium hydroxide In ethanol; water for 2 h; Heating / reflux
Stage #2: Acidic aqueous solution
4-Amino-3-chloro-N-thiazol-2-yl-benzamide : 4-Amino-3-chloro-benzoic acid methyl ester (21.6 mmol) was saponified in EtOH (25 ml) and NaOH (1M, 25 ml) at reflux for 2h. The organic solvent was evaporated and pH adjusted to 4. The product was removed by filtration, washed with water and dried in vacuo. Yield: 92percent 1H NMR (D6-DMSO) : 6.15 (s, 2H); 6.79 (d, 1H); 7.59 (dd, 1H); 7.71 (d, 1H); 12.37 (br s, 1H).
92% for 2 h; Heating / reflux 4-Amino-3-chloro-benzoic acid methyl ester (21.6 mmol) was saponified in EtOH (25 ml) and NaOH (IM5 25 ml) at reflux for 2h. The organic solvent was evaporated and pH adjusted to 4. The product was removed by filtration, washed with water and dried in vacuo to give A- amino-3-chloro-benzoic acid.Yield: 92percentIH NMR (D6-DMSO): 6.15 (s, 2H); 6.79 (d, IH); 7.59 (dd, IH); 7.71 (d, IH); 12.37 (br s,IH).
Reference: [1] Patent: WO2005/39572, 2005, A1, . Location in patent: Page/Page column 25
[2] Patent: WO2006/114093, 2006, A1, . Location in patent: Page/Page column 37
  • 2
  • [ 84228-44-4 ]
  • [ 50961-67-6 ]
  • [ 2486-71-7 ]
Reference: [1] Patent: WO2005/115147, 2005, A2, . Location in patent: Page/Page column 40
  • 3
  • [ 67-56-1 ]
  • [ 2486-71-7 ]
  • [ 84228-44-4 ]
YieldReaction ConditionsOperation in experiment
100% at 0℃; for 12 h; Reflux Example 1128-Chloro-3 ,3 -dimethyl-2- (3 -morpholin-4-yl-phenyl)- 1 ,2,3 ,4-tetrahydro-quinoline-6- carboxylic acidTo a stirred solution of 4-amino-3-chloro-benzoic acid (50 g, 291 mmol) in methanol (300 mL) was added thionyl chloride (45 mL, 605 mmol) dropewise at 0 °C. Then the mixture solution was refluxed for 12 hours before cooling to room temperature. Then the reaction mixture was concentrated in vacuo and the residue was dissolved in ethyl acetate (500 mL), washed with saturated aqueous sodium bicarbonate solution (3 x 100 mL), dried over anhydrous sodium sulfate and concentrated in vacuo to afford 4-amino-3-chloro- benzoic acid methyl ester (54 g, quant.) as a pale-white solid: LC/MS m/e calcd for C8H8C1N02 (M+H)+: 186.61, observed: 185.9.
100% at 0℃; for 12 h; Reflux To a stirred solution of 4-amino-3-chloro-benzoic acid (50 g, 291 mmol) in methanol (300 mL) was added thionyl chloride (45 mL, 605 mmol) dropewise at 0° C. Then the mixture solution was refluxed for 12 hours before cooling to room temperature. Then the reaction mixture was concentrated in vacuo and the residue was dissolved in ethyl acetate (500 mL), washed with saturated aqueous sodium bicarbonate solution (3.x.100 mL), dried over anhydrous sodium sulfate and concentrated in vacuo to afford 4-amino-3-chloro-benzoic acid methyl ester (54 g, quant.) as a pale-white solid: LC/MS m/e calcd for C8H8ClNO2 (M+H)+: 186.61, observed: 185.9.
97% at 0 - 80℃; for 6 h; To a stirring solution of 4-amino-3-chlorobenzoic acid (2.00 g, 1 1.7 mmol) in methanol (20.0 mL) at 0 °C was added concentrated H2S04 (2.00 mL) slowly. The resulting mixture was heated at 80 °C for 6 h. The reaction mixture was cooled to rt and then concentrated under reduced pressure. The residue was diluted with sat. aq. NaHC03 and extracted with ethyl acetate (2 x 50 mL). The combined organics were washed with brine, dried over anhydrous Na2S04 and then concentrated in vacuo to afford methyl 4-amino-3-chlorobenzoate (2.10 g, 97percent). -NMR (400 MHz, DMSO-c/6): δ ppm: 7.70 (d, J = 1.6 Hz, 1H), 7.58 (dd, J = 8.4, 2.0 Hz, 1H), 6.77 (d, J = 8.8 Hz, 1H), 6.24 (s, 2H), 3.73 (s, 3H)
Reference: [1] Patent: WO2011/128251, 2011, A1, . Location in patent: Page/Page column 203
[2] Patent: US2011/257151, 2011, A1, . Location in patent: Page/Page column 75
[3] Patent: WO2018/157190, 2018, A1, . Location in patent: Paragraph 0337
[4] Journal of Cellular Biochemistry, 2017, vol. 118, # 8, p. 2420 - 2429
[5] Journal of Medicinal Chemistry, 2018, vol. 61, # 3, p. 666 - 680
[6] Patent: EP2697246, 2018, B1, . Location in patent: Paragraph 0262; 0263
  • 4
  • [ 619-45-4 ]
  • [ 84228-44-4 ]
YieldReaction ConditionsOperation in experiment
83% With copper(II) choride dihydrate; lithium chloride hydrate In ethanol for 48 h; Reflux General procedure: A round-bottomed flask (25 mL) was charged with substrate (2 mmol), CuCl2·2H2O (6 mmol), LiCl·H2O (2 mmol) and EtOH (4 mL). The resulting reaction mixture was stirred at reflux. After the completion of the reaction monitored by TLC, EtOH was removed under reduced pressure. Then ammonium hydroxide (4 mL, 25percent) and water (10 mL) were added and the aqueous phase was extracted with ethyl acetate (10 mL×3). The combined organic phase was washed with brine (8 mL×3) and dried over anhydrous Na2SO4. The solvent was removed under reduced pressure. The crude mixture was purified by chromatography on silica gel to obtain the desired products.
Reference: [1] Synlett, 1999, # 12, p. 1984 - 1986
[2] Synthesis, 1985, # 6/7, p. 669 - 670
[3] Synthetic Communications, 2018, vol. 48, # 20, p. 2708 - 2714
  • 5
  • [ 21803-75-8 ]
  • [ 84228-44-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 25, p. 5277 - 5283
  • 6
  • [ 2486-71-7 ]
  • [ 77-76-9 ]
  • [ 84228-44-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 25, p. 5277 - 5283
  • 7
  • [ 74-87-3 ]
  • [ 2486-71-7 ]
  • [ 84228-44-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 22, p. 7815 - 7833
  • 8
  • [ 84228-44-4 ]
  • [ 214759-66-7 ]
YieldReaction ConditionsOperation in experiment
68%
Stage #1: With tert.-butylnitrite; boron trifluoride diethyl etherate In diethyl ether; dichloromethane at -20 - 20℃; for 72.5 h;
Stage #2: at 0 - 20℃; for 18.5 h;
Stage #3: With iron(III) chloride In water at 20℃; for 0.5 h;
A solution of methyl 4-amino-3-chlorobenzoate (5.0 g, 27 mmol) was stirred at -20°C in DCM (20 mL) and treated sequentially with a solution of BF3.0Et.2 (5.5 mL, 43 mmol) in anhydrous diethyl ether (10 mL) and ferf-butyl nitrite (6.0 mL, 46 mmol). The reaction mixture was stirred at -20°C for 30 min and then allowed to warm slowly to RT and stirred for 72 h. The reaction mixture was filtered and the precipitate was washed sequentially with DCM (50 mL), Et.20 (50 mL) and isohexane (50 mL) to afford the intermediate diazonium salt. The salt was dissolved in H2O (200 mL) and slowly added to a stirred mixture of potassium cyanide (1.98 g, 30.4 mmol) and copper (I) cyanide (2.73 g, (0572) 30.4 mmol) in H20 (300 mL) at 0-5°C. After the addition the mixture was stirred at 0-5°C for 0.5 h, then at RT for 18 h. The mixture was treated with 10percent aqueous FeC solution (200 mL) and stirred at RT for 30 min. The product was extracted with EtOAc (3 x 200 mL) and the combined organic extracts were washed with brine (400 mL), dried over MgSC , filtered and concentrated in vacuo. The product was purified by silica gel chromatography (120 g, 0-10percent EtOAc in isohexane) to afford the title compound (2) (3.56 g, 68percent) as an orange solid: m/z 196 [M+H]+ (ES+); 1 H NMR (400 MHz, DMSO-d6) δ: 8.17 - 8.14 (2H, m), 8.04 (1 H, dd), 3.91 (3H, s)
Reference: [1] Patent: WO2016/97004, 2016, A1, . Location in patent: Page/Page column 67; 68
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 84228-44-4 ]

Aryls

Chemical Structure| 41727-48-4

[ 41727-48-4 ]

Methyl 4-amino-3,5-dichlorobenzoate

Similarity: 0.95

Chemical Structure| 32961-44-7

[ 32961-44-7 ]

Isobutyl 3,5-diamino-4-chlorobenzoate

Similarity: 0.92

Chemical Structure| 40872-87-5

[ 40872-87-5 ]

Methyl 3-amino-4-chlorobenzoate

Similarity: 0.92

Chemical Structure| 21961-31-9

[ 21961-31-9 ]

Methyl 3-amino-5-chlorobenzoate

Similarity: 0.92

Chemical Structure| 120100-15-4

[ 120100-15-4 ]

Methyl 3-amino-2-chlorobenzoate

Similarity: 0.91

Chlorides

Chemical Structure| 41727-48-4

[ 41727-48-4 ]

Methyl 4-amino-3,5-dichlorobenzoate

Similarity: 0.95

Chemical Structure| 32961-44-7

[ 32961-44-7 ]

Isobutyl 3,5-diamino-4-chlorobenzoate

Similarity: 0.92

Chemical Structure| 40872-87-5

[ 40872-87-5 ]

Methyl 3-amino-4-chlorobenzoate

Similarity: 0.92

Chemical Structure| 21961-31-9

[ 21961-31-9 ]

Methyl 3-amino-5-chlorobenzoate

Similarity: 0.92

Chemical Structure| 120100-15-4

[ 120100-15-4 ]

Methyl 3-amino-2-chlorobenzoate

Similarity: 0.91

Esters

Chemical Structure| 41727-48-4

[ 41727-48-4 ]

Methyl 4-amino-3,5-dichlorobenzoate

Similarity: 0.95

Chemical Structure| 32961-44-7

[ 32961-44-7 ]

Isobutyl 3,5-diamino-4-chlorobenzoate

Similarity: 0.92

Chemical Structure| 40872-87-5

[ 40872-87-5 ]

Methyl 3-amino-4-chlorobenzoate

Similarity: 0.92

Chemical Structure| 21961-31-9

[ 21961-31-9 ]

Methyl 3-amino-5-chlorobenzoate

Similarity: 0.92

Chemical Structure| 120100-15-4

[ 120100-15-4 ]

Methyl 3-amino-2-chlorobenzoate

Similarity: 0.91

Amines

Chemical Structure| 41727-48-4

[ 41727-48-4 ]

Methyl 4-amino-3,5-dichlorobenzoate

Similarity: 0.95

Chemical Structure| 32961-44-7

[ 32961-44-7 ]

Isobutyl 3,5-diamino-4-chlorobenzoate

Similarity: 0.92

Chemical Structure| 40872-87-5

[ 40872-87-5 ]

Methyl 3-amino-4-chlorobenzoate

Similarity: 0.92

Chemical Structure| 21961-31-9

[ 21961-31-9 ]

Methyl 3-amino-5-chlorobenzoate

Similarity: 0.92

Chemical Structure| 120100-15-4

[ 120100-15-4 ]

Methyl 3-amino-2-chlorobenzoate

Similarity: 0.91